Drug resistance in tuberculosis

Mitchison D. A.

Source: Eur Respir J 2005; 25: 376-379
Journal Issue: February
Disease area: Respiratory infections

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Mitchison D. A.. Drug resistance in tuberculosis. Eur Respir J 2005; 25: 376-379

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Drug resistance in pulmonary tuberculosis in Turkey
Source: Eur Respir J 2004; 24: Suppl. 48, 657s
Year: 2004

Drug resistant tuberculosis at a drug resistant tuberculosis centre, India- Analysis of outcome
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017

Drug resistance of Mycobacterium tuberculosis to fluoroquinolones (Q)
Source: Eur Respir J 2003; 22: Suppl. 45, 41s
Year: 2003

Drug resistance to tuberculosis in Karachi
Source: Eur Respir J 2004; 24: Suppl. 48, 655s
Year: 2004

Drug resistance profiles of mycobacterium tuberculosis isolates in MDR pulmonary tuberculosis from a high burden developing country
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008


Drug resistant tuberculosis in Belarus
Source: Eur Respir J 2003; 22: Suppl. 45, 519s
Year: 2003

Drug resistance among new TB cases and relapses
Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2011

Drug resistance and tuberculosis elimination in low-incidence countries
Source: Eur Respir J 2014; 44: 1408-1411
Year: 2014


Drug resistance patterns in patients with multi-drug resistant tuberculosis (MDR – TB)
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Year: 2012


Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases
Source: Eur Respir J 2008; 31: 1155-1159
Year: 2008



Impact of resistance to first-line and injectable drugs on treatment outcomes in MDR-TB
Source: Eur Respir J 2009; 33: 581-585
Year: 2009



Drug resistance pattern & response to supervised chemotherapy of drug resistant pulmonary tuberculosis - a study of hospitalized cases from tuberculosis diseases treatment centre
Source: Eur Respir J 2003; 22: Suppl. 45, 524s
Year: 2003

Drug resistant tuberculosis in hospitalized patients
Source: Eur Respir J 2006; 28: Suppl. 50, 10s
Year: 2006

Drug resistant TB treatment outcomes in Novokuznetsk
Source: Annual Congress 2007 - Epidemiological and clinical aspects of tuberculosis control
Year: 2007


Drug resistance of Mycobacterium tuberculosis isolated from tuberculosis inflammatory foci
Source: Eur Respir J 2005; 26: Suppl. 49, 654s
Year: 2005

Drug concentration in lung tissue in multidrug-resistant tuberculosis
Source: Eur Respir J 2013; 42: 1750-1752
Year: 2013


Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB
Source: Eur Respir J 2009; 33: 1085-1094
Year: 2009



Drug resistance in pulmonary TB patients: Analysis of dynamics
Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2011


Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis
Source: Eur Respir J 2013; 42: 169-179
Year: 2013



Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones},
Source: Eur Respir J 2012; 40: 814-822
Year: 2012